Nanochemoprevention: Sustained release of bioactive food components for cancer prevention

Nutrition and Cancer

Volumn 62, Issue 7, 2010, Pages 883-890

  Siddiqui, Imtiaz A ^a   Adhami, Vaqar M ^a   Ahmad, Nihal ^a   Mukhtar, Hasan ^a  

^a Medical Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINOBENZALDEHYDE; CURCUMIN; EPIGALLOCATECHIN GALLATE; LIPOSOME; MACROGOL; NANOPARTICLE; PALMITIC ACID; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; RESVERATROL; TANNIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG RETENTION; HEAD AND NECK CARCINOMA; HUMAN; IN VIVO STUDY; LIPOSOMAL DELIVERY; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; SUSTAINED DRUG RELEASE; TARGET ORGAN;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CATECHIN; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; HUMANS; NANOCAPSULES; NANOPARTICLES; NEOPLASMS;

MUS MUSCULUS;

EID: 77958019137     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.509537     Document Type: Review

References (49)

1. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768-780, 2003.
2. Siddiqui IA, Afaq F, Adhami VM, and Mukhtar H: Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Chem Biol Interact 171, 122-132, 2008.
3. Khan N, Afaq F, and Mukhtar H: Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10, 475-510, 2008.
4. Syed DN, Khan N, Afaq F, and Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16, 2193-2203, 2007.
5. Bode AM and Dong Z: Cancer prevention research-then and now. Nat Rev Cancer 9, 508-516, 2009.
6. Amin AR, Kucuk O, Khuri FR, and Shin DM: Perspectives for cancer prevention with natural compounds. J Clin Oncol 27, 2712-2725, 2009.
7. Greenwald P: Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr 134, 3507S-3512S, 2004.
8. Khan N, Adhami VM, and Mukhtar H: Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76, 1333-1339, 2008.
9. Ferrari M: Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5, 161-171, 2005.
10. Nishiyama N: Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol 2, 203-204, 2007.
11. Nie S, Xing Y, Kim GJ, and Simons JW: Nanotechnology applications in cancer. Annu Rev Biomed Eng 9, 257-288, 2007.
12. Niemeyer CM: Semi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnology. J Biotechnol 82, 47-66, 2001.
13. Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, et al.: Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 69, 1712-1716, 2009.
14. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, et al.: Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603, 1994.
15. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al.: Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2, 751-760, 2007.
16. Kawasaki ES and Player A: Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 1, 101-109, 2005.
17. Gref R, Domb A, Quellec P, Blunk T, Müller RH, et al.: The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16, 215-233, 1995.
18. Deng C, Tian H, Zhang P, Sun J, Chen X, et al.: Synthesis and characterization of RGD peptide grafted poly (ethylene glycol)-b-poly (L-lactide)-bpoly (L-glutamic acid) triblock copolymer. Biomacromolecules 7, 590-596, 2006.
19. Mosqueira VC, Legrand P, Morgat JL, Vert M, Mysiakine E, et al.: Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res 18, 1411-1419, 2001.
20. Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AG, et al.: Surface modification of poly (lactide-co-glycolide) nanospheres by biodegradable poly (lactide)-poly (ethylene glycol) copolymers. Pharm Res 11, 1800-1808, 1994.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al.: Cancer statistics, 2009. CA Cancer J Clin 59, 225-249, 2009.
22. Khan N, Afaq F, Saleem M, Ahmad N, and Mukhtar H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66, 2500-2505, 2006.
23. Stuart EC, Scandlyn MJ, and Rosengren RJ: Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci 79, 2329-2336, 2006.
24. Saleem M, Adhami VM, Siddiqui IA, and Mukhtar H: Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer 47, 13-23, 2003. (Pubitemid 38250431)
25. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, et al.: Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila Pa) 2, 673-682, 2009.
26. Butt MS and Sultan MT: Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 49, 463-473, 2009.
27. Khan N and Mukhtar H: Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269, 269-280, 2008.
28. Mukhtar H and Ahmad N: Green tea in chemoprevention of cancer. Toxicol Sci 52, 111-117, 1999.
29. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, and Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89, 1881-1886, 1997.
30. Cao Y and Cao R: Angiogenesis inhibited by drinking tea. Nature 398, 381, 1999.
31. Daliani D: Development of angiogenesis inhibition as therapy for prostate cancer. Oncology (Williston Park) 14, 21-23, 2000.
32. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, et al.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281, 1591-1597, 1999.
33. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, et al.: Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13, 1611-1619, 2007.
34. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, et al.: Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27, 2055-2063, 2008.
35. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, et al.: Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83, 761-769, 2008.
36. Han DW, Lee JJ, Jung DY, Park JC, and Hyon SH: Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations. Biomed Mater 4, 44104, 2009.
37. Sahu A, Bora U, Kasoju N, and Goswami P: Synthesis of novel biodegradable and self-assembling methoxy poly (ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 4, 1752-1761, 2008.
38. Thangapazham RL, Puri A, Tele S, Blumenthal R, and Maheshwari RK: Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 32, 1119-1123, 2008.
39. Italia JL, Datta P, Ankola DD, and Kumar MNVR: Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution. J Biomed Nanotechnol 4, 304-312, 2008.
40. Das RK, Kasoju N, and Bora U: Encapsulation of curcumin in alginatechitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6, 153-160, 2010.
41. Merrell JG, McLaughlin SW, Tie L, Laurencin CT, Chen AF, et al.: Curcumin loaded poly (epsilon-caprolactone) nanofibers: diabetic wound dressing with antioxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol 36, 1149-1156, 2009.
42. Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y, et al.: Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol 76, 81-90, 2009.
43. Wang D, Veena MS, Stevenson K, Tang C, Ho B, et al.: Liposomeencapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14, 6228-6236, 2008.
44. Shao J, Li X, Lu X, Jiang C, Hu Y, et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 72, 40-47, 2009.
45. Caddeo C, Teskac K, Sinico C, and Kristl J: Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 363, 183-191, 2008.
46. Lu X, Ji C, Xu H, Li X, Ding H, et al.: Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int J Pharm 375, 89-96, 2009.
47. Hung CF, Chen JK, Liao MH, Lo HM, and Fang JY: Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol 6, 2950-2958, 2006.
48. Narayanan NK, Nargi D, Randolph C, and Narayanan BA: Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125, 1-8, 2009.
49. Shutava TG, Balkundi SS, Vangala P, Steffan JJ, Bigelow RL, et al.: Layerby-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano, 2009.